HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium

Journal of Neurochemistry

Volumn 84, Issue 1, 2003, Pages 169-179

  Toborek, Michal ^a   Lee, Yong Woo ^a   Pu, Hong ^a   Malecki, Andrzej ^a,c   Flora, Govinder ^a   Garrido, Rosario ^a   Hennig, Bernhard ^a   Bauer, Hans Christian ^b   Nath, Avindra ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b Institute of Molecular Biology Salzburg   (Austria)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

AIDS; Blood brain barrier; Endothelial cells; Virotoxins

Indexed keywords

CHEMOKINE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR AP 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN BLOOD VESSEL; CELL DAMAGE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMENTIA; DNA BINDING; ENDOTHELIUM CELL; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRANSACTIVATION; VASCULAR ENDOTHELIUM; VIRUS GENE;

ANIMALS; CEREBROVASCULAR CIRCULATION; CHEMOKINE CCL2; CLONE CELLS; ENDOTHELIUM, VASCULAR; GENE PRODUCTS, TAT; MICROCIRCULATION; NF-KAPPA B; OXIDATIVE STRESS; RNA, MESSENGER; SWINE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; VASCULITIS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037262112     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01543.x     Document Type: Article

References (60)

1. Ansari S. A., Safak M., Gallia G. L., Sawaya B. E., Amini S. and Khalili K. (1999) Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity. J. General Virol. 80, 2629-2638.
2. Banks W. A., Akerstrom V. and Kastin A. J. (1998) Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization coreceptor. J. Cell Sci. 111, 533-540.
3. Bassenge E. (1996) Endothelial function in different organs. Prog. Cardiovasc. Dis. 39, 209-228.
4. Bauer H., Amberger A., Bauer H. C., Webersinke G., Zach O., Olson J. W. and Hennig B. (1993) Transcription-independent activation of omithine decarboxylase activity by heparin in cloned cerebral endothelial cells. J. Neurochem. 60, 1520-1524.
5. Beg A. A., Finco T. S., Nantermet P. V. and Baldwin A. S. Jr (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκB alpha: a mechanism for NF-κB activation. Mol. Cell Biol. 13, 3301-3310.
6. Beutler E. (1989) Nutritional and metabolic aspects of glutathione. Annu. Rev. Nutr. 9, 287-302.
7. Bhat G., Tinsley S. B., Tolson J. K., Patel J. M. and Block E. R. (1992) Hypoxia increases the susceptibility of pulmonary artery endothelial cells to hydrogen peroxide injury. J. Cell. Physiol. 151, 228-238.
8. Bonwetsch R., Croul S., Richardson M. W., Lorenzana C., Valle L. D., Sverstiuk A. E., Amini S., Morgello S., Khalili K. and Rappaport J. (1999) Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders. J. Neurovirol. 5, 685-694.
9. Buttner A., Mehraein P. and Weis S. (1996) Vascular changes in the cerebral cortex in HIV-1 infection. II. An immunohistochemical and lectinhistochemical investigation. Acta Neuropathol. 92, 35-41.
10. Chang H. C., Samaniego F., Nair B. C., Buonaguro L. and Ensoli B. (1997) HIV-1 tat protein exits from cells via a leaderless secretory pathway and binds to extracellelar matrix-associated heparan sulfate proteoglycan through its basic region. AIDS 11, 1421-1431.
11. Chen P., Mayne M., Power C. and Nath A. (1997) The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J. Biol. Chem. 272, 22385-22388.
12. Cinque P., Vago L., Mengozzi M., Torri V., Ceresa D., Vicenzi E., Transidico P., Vagani A., Sozzani S., Mantovani A., Lazzarin A. and Poli G. (1997) Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 12, 1327-1332.
13. Conant K., Ma M., Nath A. and Major E. O. (1996) Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J. Virol. 70, 1384-1389.
14. Conant K., Garzino-Demo A., Nath A., McArthur J. C., Halliday W., Power C., Gallo R. C. and Major E. O. (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl Acad. Sci. USA 95, 3117-3121.
15. Deneke S. M. and Fanburg B. L. (1989) Regulation of cellular glutathione. Am. J. Physiol. 257, L163-L173.
16. Dollard S. C., James H. J., Sharer L. R., Epstein L. G., Gelbard H. A. and Dewhurst S. (1995) Activation of nuclear factor kappa B in brains from children with HIV-1 encephalitis. Neuropathol. Appl. Neurobiol. 21, 518-528.
17. Dougherty R. H., Skolasky R. L. Jr and McArthur J. C. (2002) Progression of HIV-associated dementia treated with HAART. AIDS Read 12, 69-74.
18. Droge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H. P., Roth S. and Gmunder H. (1994) Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8, 1131-1138.
19. Edinger A. L., Mankowski J. L., Doranz B. J., Margulies B. J., Lee B., Rucker J., Sharron M., Hoffman T. L., Berson J. F., Zink M. C., Hirsch V. M., Clements J. E. and Doms R. W. (1997) CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc. Natl Acad. Sci. USA 94, 14742-14747.
20. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R. A., Wingfield P. and Gallo R. C. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287.
21. Gibellini D., Re M. C., Ponti C., Celeghini C., Melloni E., La Placa M. and Zauli G. (2001) Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells. Br. J. Haematol. 112, 663-670.
22. Gius D., Botero A., Shah S. and Curry H. A. (1999) Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1. Toxicol. Lett. 106, 93-106.
23. Gurwell J. A., Nath A., Sun Q., Zhang J., Martin K. M., Chen Y. and Hauser K. F. (2001) Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 102, 555-563.
24. Hofman F. M., Dohadwala M. M., Wright A. D., Hinton D. R. and Walker S. M. (1994) Exogenous tat protein activates central nervous system-derived endothelial cells. J. Neuroimmunol. 54, 19-28.
25. Hsu T. C., Young M. R., Cmarik J. and Colbum N. H. (2000) Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)dependent transcriptional events in carcinogenesis. Free Radic. Biol. Med. 28, 1338-1348.
26. Hudson L., Liu J., Nath A., Jones M., Raghavan R., Narayan O., Male D. and Everall I. (2000) Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J. Neurovirol. 6, 145155.
27. Jiang Y., Beller D. I., Frendl G. and Graves D. T. (1992) Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J. Immunol. 148, 2423-2428.
28. Kaiser S. and Toborek M. (2001) Liposome-mediated high-efficiency transfection of human endothelial cells. J. Vasc. Res. 38, 133-143.
29. Kelder W., McArthur J. C., Nance-Sproson T., McCleron D. and Griffin D. E. (1998) Beta-Chemokines MCP-1 and RANTES are selectively increased in the cerebral spinal fluid with human immunodeficiency virus-associated dementia. Ann. Neurol. 44, 831-835.
30. Kumar A., Manna S. K., Dhawan S. and Aggarwal B. B. (1998) HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J. Immunol. 161, 776-781.
31. Kutsch O., Oh J., Nath A. and Benveniste E. N. (2000) Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74, 9214-9221.
32. Ma M. and Nath A. (1997) Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 71, 2495-2499.
33. Manna S. K. and Aggarwal B. B. (2000) Differential requirement for p561ck in HIV-tat versus TNF-induced cellular responses: effects on NF-κB, activator protein-1, c-Jun N-terminal kinase, and apoptosis. J. Immunol. 164, 5156-5166.
34. Martin T., Cardarelli P. M., Parry G. C., Felts K. A. and Cobb R. R. (1997) Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur. J. Immunol. 27, 1091-1097.
35. Mattson M. P., Barger S. W., Begley J. G. and Mark R. J. (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Meth. Cell Biol. 46, 187-215.
36. McGovern V, Bauer H. C., McClain C. J., Jackson B. and Hennig B. (1994) Tumor necrosis factor-mediated effects on gamma-glutamyl transpeptidase activity in cloned cerebral endothelial cells. Endothelium 2, 143-148.
37. Moses A. V. and Nelson J. A. (1994) HIV infection of human brain capillary endothelial cells - implications for AIDS dementia. Adv. Neuroimmunol. 4, 239-247.
38. Mukaida N., Harada A. and Matsushima K. (1998) Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev. 9, 9-23.
39. Nath A. and Geiger J. (1998) Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog. Neurobiol. 54, 19-33.
40. Nath A., Psooy K., Martin C., Knudsen B., Magnuson D. S., Haughey N. and Geiger J. D. (1996) Identification of a human immunodeficiency virus type I Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70, 1480.
41. Petito C. K. and Cash K. S. (1992) Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann. Neurol. 32, 658-666.
42. Power C., Kong P. A., Crawford T. O., Wesselingh S., Glass J. D., McArthur J. C. and Trapp B. D. (1993) Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood brain barrier. Ann. Neurol. 34, 339-350.
43. Sacktor N., Lyles R. H., Skolasky R., Kleeberger C., Seines O. A., Miller E. N., Becker J. T., Cohen B. and McArthur J. C. (2001) HIVassociated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-98. Neurology 56, 257-260.
44. Sawaya B. E., Khalili K., Gordon J., Taube R. and Amini S. (2000) Cooperative interaction between HIV-1 regulatory proteins tat and vpr modulates transcription of the viral genome. J. Biol. Chem. 275, 35209-35214.
45. Shyy Y. J., Li Y. S. and Kolattukudy P. E. (1990) Structure of human monocyte chemotactic protein gene and its regulation by TPA. Biochem. Biophys. Res. Commun. 169, 346-351.
46. Staddon J. M., Herrenknecht K., Schulze C., Smales C. and Rubin L. L. (1995) Signal transduction at the blood-brain barrier. Biochem. Soc. Trans. 23, 475-479.
47. Strelow L. I., Watry D. D., Fox H. S. and Nelson J. A. (1998) Efficient infection of brain microvascular endothelial cells by an in vivoselected neuroinvasive SIVmac variant. J. Neurovirol. 4, 269-280.
48. Suttorp N., Toepfer W. and Roka L. (1986) Antioxidant defense mechanisms of endothelial cells: glutathione redox cycle versus catalase. Am. J. Physiol. 251, C671-C680.
49. Takahashi K., Wesselingh S. L., Griffin D. E., McArthur J. C., Johnson R. T. and Glass J. D. (1996) Localization of HIV-I in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39, 705-711.
50. Tietze F. (1969) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal. Biochem. 27, 502-522.
51. Toborek M. and Hennig B. (1994) Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells. Am. J. Clin. Nutr. 59, 60-65.
52. Toborek M., Barger S. W., Mattson M. P., McClain C. J. and Hennig B. (1995) Role of glutathione redox cycle in TNF-mediated endothelial cell dysfunction. Atherosclerosis 117, 179-188.
53. Toborek M., Barger S. W., Mattson M. P., Barve S., McClain C. J. and Hennig B. (1996) Linoleic acid and TNF-α cross-amplify oxidative injury and dysfunction of endothelial cells. J. Lipid Res. 37, 123135.
54. Toborek M., Lee Y. W., Kaiser S. and Hennig B. (2002) Measurements of inflammatory properties of fatty acids in human endothelial cells. Meth. Enzymol. 352, 198-219.
55. Valle L. D., Croul S., Morgello S., Amini S., Rappaport J. and Khalili K. (2000) Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J. Neurovirol. 6, 221-228.
56. Weis S., Haug H. and Budka H. (1996) Vascular changes in the cerebral cortex in HIV-1 infection: I. A morphometric investigation by light and electron microscopy. Clin. Neuropathol. 15, 361-366.
57. Weiss J. M., Nath A., Major E. O. and Berman J. W. (1999) HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J. Immunol. 163, 2953-2959.
58. Wu D. T., Woodman S. E., Weiss J. M., McManus C. M., D'Aversa T. G., Hesselgesser J., Major E. O., Nath A. and Berman J. W. (2000) Mechanisms of leukocyte trafficking into the CNS. J. Neurovirol. 6, S82-S85.
59. Xanthoudakis S., Miao G., Wang F., Pan Y. C. and Curran T. (1992) Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11, 3323-3335.
60. Zidovetzki R., Wang J. L., Chen P., Jeyaseelan R. and Hofman F. (1998) Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP-dependent protein kinase pathways. AIDS Res. Hum. Retroviruses 14, 825-833.